Literature DB >> 20412779

Evidence for a myotomal Hox/Myf cascade governing nonautonomous control of rib specification within global vertebral domains.

Tânia Vinagre1, Natalia Moncaut, Marta Carapuço, Ana Nóvoa, Joana Bom, Moisés Mallo.   

Abstract

Hox genes are essential for the patterning of the axial skeleton. Hox group 10 has been shown to specify the lumbar domain by setting a rib-inhibiting program in the presomitic mesoderm (PSM). We have now produced mice with ribs in every vertebra by ectopically expressing Hox group 6 in the PSM, indicating that Hox genes are also able to specify the thoracic domain. We show that the information provided by Hox genes to specify rib-containing and rib-less areas is first interpreted in the myotome through the regional-specific control of Myf5 and Myf6 expression. This information is then transmitted to the sclerotome by a system that includes FGF and PDGF signaling to produce vertebrae with or without ribs at different axial levels. Our findings offer a new perspective of how Hox genes produce global patterns in the axial skeleton and support a redundant nonmyogenic role of Myf5 and Myf6 in rib formation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412779     DOI: 10.1016/j.devcel.2010.02.011

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  31 in total

1.  cis-regulatory change associated with snake body plan evolution.

Authors:  Jennifer H Mansfield
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-07       Impact factor: 11.205

2.  Evolution of transcriptional enhancers and animal diversity.

Authors:  Marcelo Rubinstein; Flávio S J de Souza
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-11-11       Impact factor: 6.237

3.  Recessive MYF5 Mutations Cause External Ophthalmoplegia, Rib, and Vertebral Anomalies.

Authors:  Silvio Alessandro Di Gioia; Sherin Shaaban; Beyhan Tüysüz; Nursel H Elcioglu; Wai-Man Chan; Caroline D Robson; Kirsten Ecklund; Nicole M Gilette; Azmi Hamzaoglu; Gulsen Akay Tayfun; Elias I Traboulsi; Elizabeth C Engle
Journal:  Am J Hum Genet       Date:  2018-06-07       Impact factor: 11.025

4.  Role of a polymorphism in a Hox/Pax-responsive enhancer in the evolution of the vertebrate spine.

Authors:  Isabel Guerreiro; Andreia Nunes; Joost M Woltering; Ana Casaca; Ana Nóvoa; Tânia Vinagre; Margaret E Hunter; Denis Duboule; Moisés Mallo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-14       Impact factor: 11.205

Review 5.  Hox genes and regional patterning of the vertebrate body plan.

Authors:  Moises Mallo; Deneen M Wellik; Jacqueline Deschamps
Journal:  Dev Biol       Date:  2010-05-07       Impact factor: 3.582

Review 6.  Axial and limb muscle development: dialogue with the neighbourhood.

Authors:  Marianne Deries; Sólveig Thorsteinsdóttir
Journal:  Cell Mol Life Sci       Date:  2016-06-25       Impact factor: 9.261

7.  Development of the mammalian axial skeleton requires signaling through the Gα(i) subfamily of heterotrimeric G proteins.

Authors:  Nicholas W Plummer; Karsten Spicher; Jason Malphurs; Haruhiko Akiyama; Joel Abramowitz; Bernd Nürnberg; Lutz Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-11       Impact factor: 11.205

Review 8.  Evolution of gene regulatory networks controlling body plan development.

Authors:  Isabelle S Peter; Eric H Davidson
Journal:  Cell       Date:  2011-03-18       Impact factor: 41.582

9.  Defective cranial skeletal development, larval lethality and haploinsufficiency in Myod mutant zebrafish.

Authors:  Yaniv Hinits; Victoria C Williams; Dylan Sweetman; Thomas M Donn; Taylur P Ma; Cecilia B Moens; Simon M Hughes
Journal:  Dev Biol       Date:  2011-07-23       Impact factor: 3.582

10.  Evolving Hox activity profiles govern diversity in locomotor systems.

Authors:  Heekyung Jung; Esteban O Mazzoni; Natalia Soshnikova; Olivia Hanley; Byrappa Venkatesh; Denis Duboule; Jeremy S Dasen
Journal:  Dev Cell       Date:  2014-04-17       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.